Abstract:Background: Despite the introduction of targeted therapies, most patients with myeloid malignancies will not be cured and progress. Genomics is useful to elucidate the mutational landscape but remains limited in the prediction of therapeutic outcome and identification of targets for resistance. Dysregulation of phosphorylation-based signaling pathways is a hallmark of cancer, and therefore, kinase-inhibitors are playing an increasingly important role as targeted treatments. Untargeted phosphoproteomics analysis pipelines have been published but show limitations in inferring kinase-activities and identifying potential biomarkers of response and resistance. Methods: We developed a phosphoproteomics workflow based on titanium dioxide phosphopeptide enrichment with subsequent analysis by liquid chromatography tandem mass spectrometry (LC-MS). We applied a novel Kinase-Activity Enrichment Analysis (KAEA) pipeline on differential phosphoproteomics profiles, which is based on the recently published SetRank enrichment algorithm with reduced false positive rates. Kinase activities were inferred by this algorithm using an extensive reference database comprising five experimentally validated kinase-substrate meta-databases complemented with the NetworKIN in-silico prediction tool. For the proof of concept, we used human myeloid cell lines (K562, NB4, THP1, OCI-AML3, MOLM13 and MV4-11) with known oncogenic drivers and exposed them to clinically established kinase-inhibitors. Results: Biologically meaningful over- and under-active kinases were identified by KAEA in the unperturbed human myeloid cell lines (K562, NB4, THP1, OCI-AML3 and MOLM13). To increase the inhibition signal of the driving oncogenic kinases, we exposed the K562 (BCR-ABL1) and MOLM13/MV4-11 (FLT3-ITD) cell lines to either Nilotinib or Midostaurin kinase inhibitors, respectively. We observed correct detection of expected direct (ABL, KIT, SRC) and indirect (MAPK) targets of Nilotinib in K562 as well as indirect (PRKC, MAPK, AKT, RPS6K) targets of Midostaurin in MOLM13/MV4-11, respectively. Moreover, our pipeline was able to characterize unexplored kinase-activities within the corresponding signaling networks. Conclusions: We developed and validated a novel KAEA pipeline for the analysis of differential phosphoproteomics MS profiling data. We provide translational researchers with an improved instrument to characterize the biological behavior of kinases in response or resistance to targeted treatment. Further investigations are warranted to determine the utility of KAEA to characterize mechanisms of disease progression and treatment failure using primary patient samples.

Inferring the Sign of Kinase-Substrate Interactions by Combining Quantitative Phosphoproteomics with a Literature-Based Mammalian Kinome Network

Phosphoproteomics data-driven signalling network inference: does it work?

Evaluating signaling pathway inference from kinase-substrate interactions and phosphoproteomics data

Inference of kinase-signaling networks in human myeloid cell line models by Phosphoproteomics using kinase activity enrichment analysis (KAEA)

Comprehensive evaluation of phosphoproteomic-based kinase activity inference

Quantitative phosphoproteomics-based molecular network description for high-resolution kinase-substrate interactome analysis

Using Propensity Scores to Predict the Kinases of Unannotated Phosphopeptides

Data-driven extraction of human kinase-substrate relationships from omics datasets

Improving the Performance of Protein Kinase Identification Via High Dimensional Protein-Protein Interactions and Substrate Structure Data

Identifying Interactions Between Kinases and Substrates Based on Protein-Protein Interaction Network.

A Novel Phosphorylation Site-Kinase Network-Based Method for the Accurate Prediction of Kinase-Substrate Relationships.

PhosD: Inferring Kinase-Substrate Interactions Based on Protein Domains.

A knowledge graph representation learning approach to predict novel kinase-substrate interactions

Systematic Analysis of Protein Phosphorylation Networks From Phosphoproteomic Data

Reconstructing kinase network topologies from phosphoproteomics data reveals cancer-associated rewiring

Effective Identification of Kinase-Specific Phosphorylation Sites Based on Domain–domain Interactions

KSP: an Integrated Method for Predicting Catalyzing Kinases of Phosphorylation Sites in Proteins.

Phosphopredict: A Bioinformatics Tool for Prediction of Human Kinase-Specific Phosphorylation Substrates and Sites by Integrating Heterogeneous Feature Selection

Large-scale Prediction of Human Kinase-Inhibitor Interactions Using Protein Sequences and Molecular Topological Structures.

Phosphomatics: interactive interrogation of substrate–kinase networks in global phosphoproteomics datasets